An honest look at the evidence, including where the famous 78% comes from.
The short answer: there's no single success rate for The Sinclair Method, but naltrexone, the medicine it uses, is well established.
The World Health Organization lists it as an essential medicine for alcohol use disorder, and UK clinical guidelines describe it, taken daily, as a first-line treatment.1,2 In controlled trials of taking it before drinking, the Sinclair Method way, people cut their heavy and binge drinking more than people taking a placebo.3,4
Yes, the controlled trials show it can help people drink less, especially with support alongside.
In these trials, some people take naltrexone and others take a placebo, so you can see what the medicine itself adds.3,4,7,8
The Sinclair Method means taking naltrexone, a prescription medicine, before drinking. The idea is that, over time, drinking becomes less rewarding, so the desire to drink gradually eases. Here's what the trials found.
People took naltrexone or a placebo daily for 12 weeks, then only when they felt a craving for a further 20 weeks. Naltrexone made the biggest difference for people who also had coping-skills sessions: 27% of them had no return to heavy drinking over the 32 weeks, compared with 3% on placebo. For people given general support only, it didn't beat placebo, and about a third of people had left the trial by the end.3
The key Finnish trial
No return to heavy drinking over 32 weeks
People who also had coping-skills sessions
Source: Heinälä P and colleagues, Journal of Clinical Psychopharmacology, 2001.3 121 people in total. Scale runs from 0 to 40%. For people given general support only, naltrexone didn't beat placebo.
People took a tablet, either naltrexone or a placebo, ahead of situations they saw as high risk. Planning ahead like this helped people drink less even on a placebo, and naltrexone added to that. In the 2006 study, everyone also had brief coping-skills sessions.7,8
In this trial of sexual and gender minority men with mild to moderate alcohol problems, naltrexone taken before likely drinking, with weekly counselling, led to 26% fewer binge-drinking days than placebo over 12 weeks, and fewer drinks overall. Six months after treatment ended, the people who'd taken naltrexone were still drinking less than those who'd had a placebo.4
Brain scans let researchers see what alcohol does inside the brain, rather than relying on how people say they feel. In 2012, a team in California used PET scans to show that a drink releases the brain's own feel-good chemicals, endorphins, in two reward areas. The more endorphins released, the better people felt. That is the system naltrexone blocks.16
Other studies scanned people while they were shown drinks. On naltrexone, a reward area called the ventral striatum reacted less.17,18 In a 2017 US trial of 152 people, those whose response dropped most went on to drink heavily the least.19 Two German studies found naltrexone helped most in people whose brains reacted strongly to drink cues.20,21 Most of these studies were small, but they all point the same way.
A Cochrane review of 50 trials and 7,793 people found naltrexone lowered the risk of heavy drinking to 83% of the risk on a dummy pill, and concluded it appears effective and safe.9 A 2023 review of 118 trials concluded that naltrexone is a first-line medicine for alcohol problems, alongside support.10 Most of these trials used a daily dose, rather than the "targeted" approach Dr Sinclair championed of taking it before drinking.
In 2023, the World Health Organization added naltrexone to its list of essential medicines. Its expert committee noted that naltrexone's benefits may be greater in people whose drinking is driven by reward, which is what The Sinclair Method is designed to work on.1 WHO guidance also recommends medicine and psychosocial support together for alcohol dependence.11 UK clinical guidelines describe naltrexone, taken daily, as a first-line treatment to prevent relapse, as part of a psychosocial treatment plan.2 NICE also recommends a related medicine, nalmefene, taken on days when drinking is likely, for some adults with alcohol dependence who want to cut down, always with ongoing support. It's a different medicine, and NICE's guidance isn't about The Sinclair Method itself.12
Put simply: the research shows real, modest reductions in heavy and binge drinking in the groups studied, and the results are strongest when people have support alongside. It can't promise any one person a result, and the longest controlled follow-ups we know of run to around six months after treatment ends.
Trials only tell part of the story. Alongside them, a growing number of people are sharing their own experience of The Sinclair Method, in books, on podcasts, in online communities and on social media. Awareness is growing, and so is the number of people who say it helped them change their relationship with alcohol.
Personal stories aren't clinical evidence. They're known as anecdotal evidence, and they can't tell you what will happen for you. But they matter, in the same way you'd read other people's reviews before any big decision. They show what change can look like in real life, from people who've lived it.

I'm one of those real-life stories. The Sinclair Method is how I got my choice back around drinking. Today alcohol is a non-issue for me: I rarely even think about it. It changed my life enough that I wanted to share this option with the world, and that's why I started Rethink Drink. You can see the early part of my journey on my YouTube channel.
You'll often see The Sinclair Method described as having a 78% success rate. It comes from Dr Sinclair's own clinics in Finland in the 1990s, where people took naltrexone before drinking, alongside counselling, for around 110 days. Over that time, their craving for alcohol steadily went down. He first reported the figure in 1998 and described it again in 2001.5,6 In his words:
On average, those 115 people had cut down to about nine drinks a week. And 38 of the 147 (26%) had stopped drinking altogether, even though only 3% had set that as their goal.6
Inside the 78%
What the clinic figure counts
Patients who completed enough treatment to be classified: 147
Source: Sinclair JD, Alcohol and Alcoholism, 2001.6 Dr Sinclair's own clinics in Finland, no placebo group.
That's an encouraging result from real patients, and it's a big part of why the method spread. It just isn't the kind of figure that can promise you a result:
Dr Sinclair's team also followed up some of these patients around two and a half years later. Of those who replied, all 27 who were still taking naltrexone before drinking said they were drinking less than before treatment, compared with 8 of the 30 who had stopped taking it. It's a small, self-reported follow-up with no comparison group, but it's the longest look at the approach we have.6
The long view
Drinking less than before treatment, around two and a half years later
Patients who replied to the follow-up
Source: Sinclair JD, Alcohol and Alcoholism, 2001.6 Small and self-reported, with no comparison group.
We used to quote the 78% ourselves, like most people in this field. When we went back to the original papers, we decided the fuller picture was more useful to you, and that the trials make a strong case on their own. If you spot the old figure on an older page of ours, it's on our list to update.
Success looks different for everyone. For some people it's fewer drinks on the nights they do drink. For others it's more alcohol-free days, or less alcohol noise in their head about the next one. Some people decide to stop altogether, and that's their call to make, now or later.
That fits the evidence too. The World Health Organization counts reducing drinking, not only stopping, as a goal of treatment,13 and Dr Sinclair wrote that success should be judged by "the health and satisfaction of the patients".6
The Sinclair Method isn't a quick fix, and naltrexone isn't a magic pill. It's gradual by design, and anyone who gives you an exact timeline is guessing. It depends on taking the medication as your prescriber directs, having patience, trusting the process, and knowing what you want to get out of it. Progress, not perfection.
Support makes a real difference. Naltrexone is studied and recommended as part of a package with support, not on its own.
Support matters, and so does the kind of support
The World Health Organization found that naltrexone with psychosocial support works better than either on its own.11
In Dr Sinclair's review of the trials, naltrexone's benefits showed up with coping-skills therapy, which accepts that slips happen, but not with support that demanded complete abstinence.6
In the key Finnish trial, naltrexone helped most for people who also had coping-skills sessions.3 That's why coaching sits at the heart of what we do: planning ahead, staying consistent, and building the skills for the moments that decide whether change sticks. Our coaching itself hasn't been tested in a trial, and we won't pretend otherwise. But it's built around what those programmes worked on, and on our own experience, refined over thousands of coaching calls with our members. Clinical decisions are made by Professor Jonathan Chick, consultant psychiatrist and our clinical lead, or by an independent prescriber.
The Sinclair Method is one route, not the only one. Some people do best stopping altogether with support. There are other medicines, such as acamprosate, as well as talking therapies and free local alcohol services. The NHS sets out the options: alcohol-use disorder, treatment and support.14 The right choice is the one that fits you.
Whether naltrexone is suitable for you is a medical decision, made after a consultation. It usually isn't suitable, or needs extra care, if you:
If you drink heavily every day, please don't stop or cut down sharply without medical advice. As the NHS puts it, "It can be very dangerous to stop drinking suddenly if you're dependent on alcohol." Call 999 or go to A&E if you or someone else has severe withdrawal symptoms, such as shaking visibly, confusion, seeing or hearing things that aren't there, or a seizure.14
There's no single agreed figure. The often-quoted 78% comes from Dr Sinclair's own clinics in Finland. Controlled trials show smaller but real reductions in heavy drinking compared with placebo, and the best results when people have support alongside.
Controlled trials show it can help people drink less. In the key Finnish trial, 27% of people taking naltrexone with coping-skills sessions had no return to heavy drinking over 32 weeks, compared with 3% on placebo. Results vary from person to person.
From Dr Sinclair's 2001 paper on his clinics in Finland: 115 of the 147 patients who completed enough treatment to be classified were considered successful. There was no placebo group, and the paper doesn't say how many people started.
A Cochrane review of 50 trials and 7,793 people found naltrexone lowered the risk of heavy drinking to 83% of the risk on a dummy pill. The World Health Organization lists it as an essential medicine for alcohol use disorder.
The fair ones: the 78% comes from clinic data with no comparison group, most large trials used naltrexone daily rather than before drinking, and it doesn't work for everyone. On the other side are controlled trials of taking it before drinking, and brain-scan studies showing how it works.
It's gradual: months rather than days, and it varies. In Dr Sinclair's clinics, people followed the method for around 110 days. More on how long The Sinclair Method takes to work.
This page was last updated on 3 November 2026 by Matt Brindley, co-founder of Rethink Drink.
